ASIA PACIFIC BONE GRAFTS AND SUBSTITUTE MARKET FORECAST 2018-2026

ASIA PACIFIC BONE GRAFTS AND SUBSTITUTE MARKET FORECAST 2018-2026

  • October 2018 •
  • 81 pages •
  • Report ID: 5586175 •
  • Format: PDF
KEY FINDINGS
The market worth of Asia-Pacific bone graft and substitute market is predicted to increase at a CAGR of 5.82% over the forecast period of 2018-2026. Increasing elderly population base is a major revenue booster for all orthopaedic related ailments market in this region.

MARKET INSIGHTS
The Asia-Pacific bone graft and substitute market is being presented with opportunities like rising reimbursement for surgeries in countries like India, Japan, China, South Korea, Australia, etc. and the development of hybrid material for bone grafting due to extensive research and investment in bioengineering. However, certain aspects like high costs associated with surgeries, off-label use of bone grafts, risks associated with the rejection of graft due to patient’s immune response, and shifting focus towards stem cell-derived products are resisting the market expansion.

COMPETITIVE INSIGHTS
Medtronic Inc, Zimmer Biomet Holdings Inc, Allosource Inc, Baxter International Inc, XTANT Medical and Wright Medical Group N.V Holdings Inc, Sigmagraft, Nuvasive Inc, Orthofix Holdings Inc, Integra Lifesciences Corp and Depuy Synthes Inc are some of the eminent players in this market.